{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:10:25Z","timestamp":1791897025760,"version":"4.3.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002371"],"award-info":[{"award-number":["TL1TR002371"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CSRD IK2CX00253"],"award-info":[{"award-number":["CSRD IK2CX00253"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002369"],"award-info":[{"award-number":["UL1TR002369"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PCO pilot award"},{"name":"Parkinson\u2019s Disease Research, Education, Clinical Center at the VA Portland Health Care System"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Huntington\u2019s disease (HD) is a devastating neurodegenerative disorder characterized by a variety of debilitating symptoms including abnormal motor control, cognitive impairment, and psychiatric disturbances. Despite significant efforts, efficacious treatments to alter the course of HD remain elusive, highlighting the need to explore new therapeutic strategies, including lifestyle changes that may delay the onset of symptoms and slow disease progression. Recent research indicates that time-restricted eating (TRE), a type of intermittent fasting where caloric intake is confined to a specific time window each day, may be beneficial in treating neurodegenerative diseases like HD. TRE has been found to enhance mitochondrial function, stimulate autophagy, lower oxidative stress, and improve cognitive performance. Although TRE has shown potential in HD animal models and non-HD populations, it has yet to be analyzed for safety, feasibility, and efficacy in persons with HD. Therefore, we propose a prospective interventional, open-label, single-arm, pilot study of 25 participants with late prodromal and early manifest HD to evaluate participant adherence to TRE diet \u2013 specifically, maintaining a 6-8-hour eating window every day for 12 weeks. Secondary measures will include pre- versus post-intervention assessment of body composition via bioelectrical impedance analysis, vital signs and safety labs, serum biomarkers of neurodegeneration, and standard HD behavioral, cognitive, and motor function clinical scales. Additional exploratory measures will evaluate sleep quality, physical activity, mood, dietary composition, and mitochondrial function. We expect that the diet will be safe, feasible, and may also improve biomarkers of disease progression in persons with HD. We anticipate this study will lay the foundation for future large-scale clinical trials to further evaluate the clinical efficacy of TRE in HD. This study has been registered on July 8, 2024 with ClinicalTrials.gov registration number NCT06490367 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06490367\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/study\/NCT06490367<\/jats:ext-link>).<\/jats:p>","DOI":"10.1371\/journal.pone.0319253","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T21:43:57Z","timestamp":1742939037000},"page":"e0319253","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Time-restricted eating in early-stage Huntington\u2019s disease: A 12-week interventional clinical trial protocol"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-7863","authenticated-orcid":true,"given":"Russell G.","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-0344","authenticated-orcid":true,"given":"Lee E.","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"McHill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie L.","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"5","key":"pone.0319253.ref001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"JP Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"pone.0319253.ref002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JHD-170270","article-title":"Age at death and causes of death in patients with Huntington disease in Norway in 1986-2015","volume":"7","author":"OK Solberg","year":"2018","journal-title":"J Huntingtons Dis"},{"key":"pone.0319253.ref003","doi-asserted-by":"crossref","first-page":"111617","DOI":"10.1016\/j.exger.2021.111617","article-title":"The effects of intermittent fasting regimens in middle-age and older adults: Current state of evidence","volume":"156","author":"S Anton","year":"2021","journal-title":"Exp Gerontol"},{"key":"pone.0319253.ref004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchemneu.2017.10.001","article-title":"Beneficial effects of dietary restriction in aging brain","volume":"95","author":"IKH Hadem","year":"2019","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"pone.0319253.ref005","doi-asserted-by":"crossref","first-page":"e20190086","DOI":"10.1084\/jem.20190086","article-title":"Effects of dietary restriction on neuroinflammation in neurodegenerative diseases","volume":"218","author":"L Fontana","year":"2021","journal-title":"J Exp Med"},{"issue":"9","key":"pone.0319253.ref006","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3390\/nu12092644","article-title":"Intermittent fasting enhanced the cognitive function in older adults with mild cognitive impairment by inducing biochemical and metabolic changes: a 3-year progressive study","volume":"12","author":"TC Ooi","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"pone.0319253.ref007","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","article-title":"Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington\u2019s disease","volume":"21","author":"A Johri","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"3","key":"pone.0319253.ref008","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12041-018-0957-1","article-title":"Huntington\u2019s disease: the coming of age","volume":"97","author":"M Pandey","year":"2018","journal-title":"J Genet"},{"issue":"3","key":"pone.0319253.ref009","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00415-018-8940-6","article-title":"Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration","volume":"266","author":"S Podvin","year":"2019","journal-title":"J Neurol"},{"issue":"11","key":"pone.0319253.ref010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington\u2019s disease","volume":"29","author":"JF Gusella","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"pone.0319253.ref011","first-page":"397","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","author":"the PREDICT-HD Investigators of the Huntington Study Group","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"pone.0319253.ref012","first-page":"887-900.e14","article-title":"CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset","volume":"178","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. Electronic address: gusella@helix.mgh.harvard.edu, Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium","year":"2019","journal-title":"Cell"},{"issue":"3","key":"pone.0319253.ref013","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of huntington\u2019s disease","volume":"162","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium","year":"2015","journal-title":"Cell"},{"issue":"10","key":"pone.0319253.ref014","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"NS Wexler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"pone.0319253.ref015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/mds.23108","article-title":"A retrospective study of the impact of lifestyle on age at onset of Huntington disease","volume":"25","author":"MK Trembath","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"pone.0319253.ref016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-024-00406-z","article-title":"Dietary fasting and time-restricted eating in Huntington\u2019s disease: therapeutic potential and underlying mechanisms","volume":"13","author":"RG Wells","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"5","key":"pone.0319253.ref017","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"W Duan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0319253.ref018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-018-0518-0","article-title":"Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease","volume":"6","author":"DE Ehrnhoefer","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"pone.0319253.ref019","doi-asserted-by":"crossref","first-page":"ENEURO.0431-17.2017","DOI":"10.1523\/ENEURO.0431-17.2017","article-title":"Time-restricted feeding improves circadian dysfunction as well as motor symptoms in the Q175 mouse model of Huntington\u2019s disease","volume":"5","author":"H-B Wang","year":"2018","journal-title":"eNeuro"},{"issue":"5","key":"pone.0319253.ref020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0748730418790401","article-title":"Circadian-based treatment strategy effective in the BACHD mouse model of Huntington\u2019s disease","volume":"33","author":"DS Whittaker","year":"2018","journal-title":"J Biol Rhythms"},{"key":"pone.0319253.ref021","doi-asserted-by":"crossref","first-page":"931636","DOI":"10.3389\/fnbeh.2022.931636","article-title":"Time-restricted ketogenic diet in Huntington\u2019s disease: a case study","volume":"16","author":"MCL Phillips","year":"2022","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"pone.0319253.ref022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/NHA-170036","article-title":"Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: a pilot study","volume":"4","author":"K Gabel","year":"2018","journal-title":"Nutr Healthy Aging"},{"issue":"4","key":"pone.0319253.ref023","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JHD-210488","article-title":"Quantifying the onset of unintended weight loss in Huntington\u2019s disease: a retrospective analysis of Enroll-HD","volume":"10","author":"AC Ogilvie","year":"2021","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"pone.0319253.ref024","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11357-020-00156-6","article-title":"Short-term time-restricted feeding is safe and feasible in non-obese healthy midlife and older adults","volume":"42","author":"CR Martens","year":"2020","journal-title":"Geroscience"},{"key":"pone.0319253.ref025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","article-title":"Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study","volume":"6","author":"JS Paulsen","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"458","key":"pone.0319253.ref026","doi-asserted-by":"crossref","first-page":"eaat7108","DOI":"10.1126\/scitranslmed.aat7108","article-title":"Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease","volume":"10","author":"LM Byrne","year":"2018","journal-title":"Sci Transl Med"},{"issue":"2","key":"pone.0319253.ref027","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"DJ Buysse","year":"1989","journal-title":"Psychiatry Res"},{"issue":"2","key":"pone.0319253.ref028","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"pone.0319253.ref029","doi-asserted-by":"crossref","unstructured":"Thames Q, Karpur A, Norris W, Xia F, Panait L, Weyand T, et al., editors. Nutrition5k: towards automatic nutritional understanding of generic food. 2021 IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR); 2021 Jun 20\u201325. .","DOI":"10.1109\/CVPR46437.2021.00879"},{"issue":"574","key":"pone.0319253.ref030","doi-asserted-by":"crossref","first-page":"eabc2888","DOI":"10.1126\/scitranslmed.abc2888","article-title":"Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington\u2019s disease","volume":"12","author":"FB Rodrigues","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7","key":"pone.0319253.ref031","doi-asserted-by":"crossref","first-page":"e0200465","DOI":"10.1371\/journal.pone.0200465","article-title":"Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures","volume":"13","author":"N Achamrah","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"pone.0319253.ref032","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"LM Byrne","year":"2017","journal-title":"Lancet Neurol"},{"key":"pone.0319253.ref033","doi-asserted-by":"crossref","first-page":"779890","DOI":"10.3389\/fneur.2021.779890","article-title":"Evaluation of blood glial fibrillary acidic protein as a potential marker in Huntington\u2019s disease","volume":"12","author":"H You","year":"2021","journal-title":"Front Neurol"},{"issue":"4","key":"pone.0319253.ref034","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/sleep\/15.4.376","article-title":"Reliability and factor analysis of the Epworth Sleepiness Scale","volume":"15","author":"MW Johns","year":"1992","journal-title":"Sleep"},{"issue":"4","key":"pone.0319253.ref035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"ZS Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"pone.0319253.ref036","doi-asserted-by":"crossref","first-page":"100245","DOI":"10.1016\/j.xpro.2020.100245","article-title":"Measurement of mitochondrial respiration in adherent cells by Seahorse XF96 Cell Mito Stress Test","volume":"2","author":"X Gu","year":"2020","journal-title":"STAR Protoc"},{"issue":"7","key":"pone.0319253.ref037","doi-asserted-by":"crossref","first-page":"e3980","DOI":"10.21769\/BioProtoc.3980","article-title":"Ex vivo assessment of mitochondrial function in human peripheral blood mononuclear cells using XF analyzer","volume":"11","author":"A Sch\u00f6ller-Mann","year":"2021","journal-title":"Bio Protoc"},{"issue":"2","key":"pone.0319253.ref038","first-page":"117","article-title":"Intermittent fasting and weight loss: systematic review","volume":"66","author":"S Welton","year":"2020","journal-title":"Can Fam Physician"},{"issue":"16","key":"pone.0319253.ref039","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa2114833","article-title":"Calorie restriction with or without time-restricted eating in weight loss","volume":"386","author":"D Liu","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0319253.ref040","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.isci.2020.101161","article-title":"Time-restricted eating: benefits, mechanisms, and challenges in translation","volume":"23","author":"P Regmi","year":"2020","journal-title":"iScience"},{"issue":"8","key":"pone.0319253.ref041","doi-asserted-by":"crossref","first-page":"e071380","DOI":"10.1136\/bmjopen-2022-071380","article-title":"Protocol for a multicentre cross-sectional, longitudinal ambulatory clinical trial in rheumatoid arthritis and Parkinson\u2019s disease patients analysing the relation between the gut microbiome, fasting and immune status in Germany (ExpoBiome)","volume":"13","author":"B Hansen","year":"2023","journal-title":"BMJ Open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T21:45:39Z","timestamp":1742939139000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319253"}},"subtitle":[],"editor":[{"given":"Jussi","family":"Sipil\u00e4,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319253","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}